Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests – Quarterly Update Report
· finance.yahoo.com
Download the Complete Report Here Aurora Cannabis Inc. (ACB) International Medical Growth Absorbs Much of Canadian Pricing Reset; Safari and Germany Momentum Strengthen the Medium-Term Growth Outlook. Attractively Valued. Key Takeaways: International medical cannabis revenue increased 17% to C$43.3 million in 1Q FY27, reinforcing ACB’s leadership across global medical markets. Adjusted gross margin reached 58%, […] The post Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests
Best-in-class global medical operations continue to diversify ACB's growth profile beyond Canada. Leadership positions in Germany, Poland, Australia, and New Ze...